Literature DB >> 18469835

Cardiometabolic risk: a Framingham perspective.

P W F Wilson1, J B Meigs.   

Abstract

OBJECTIVE: To review published data on vascular disease- and diabetes-related outcomes related to adiposity and metabolic risk factors.
DESIGN: Community cohort study with cross-sectional and prospective data.
SUBJECTS: Middle-aged Caucasian adults in a suburban environment. MEASUREMENTS: Traditional risk factors for cardiovascular disease and the type 2 diabetes mellitus, as well as measures of insulin resistance, left ventricular hypertrophy and vascular calcification.
RESULTS: The cardiometabolic risk factors cluster in the population and a common core that includes adiposity (both waist and body mass index), abnormal lipids (both HDL cholesterol and triglycerides), and abnormal glucose and insulin metabolism was found to be present in Framingham participants. Increased insulin resistance was also found to be associated with coronary artery calcification and left ventricular hypertrophy in women. Analyses of the metabolic syndrome risk factors showed that a greater burden of risk factors was associated with greater risk of both cardiovascular disease and diabetes mellitus. An equation to estimate risk of developing type 2 diabetes mellitus has been developed from the Framingham experience, and the risk factors included in the metabolic syndrome are key components, including increased waist girth, elevated blood pressure, low HDL cholesterol, high triglycerides and impaired fasting glucose.
CONCLUSION: Cardiometabolic factors and insulin resistance are important contributors to the development of type 2 diabetes mellitus, subclinical cardiovascular disease and clinical cardiovascular disease.

Entities:  

Mesh:

Year:  2008        PMID: 18469835     DOI: 10.1038/ijo.2008.30

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  16 in total

1.  Stress and cardiovascular disease risk in female law enforcement officers.

Authors:  Hyelim Yoo; Warren D Franke
Journal:  Int Arch Occup Environ Health       Date:  2010-05-28       Impact factor: 3.015

2.  Neighborhood cohesion, neighborhood disorder, and cardiometabolic risk.

Authors:  Jennifer W Robinette; Susan T Charles; Tara L Gruenewald
Journal:  Soc Sci Med       Date:  2017-12-18       Impact factor: 4.634

Review 3.  Molecular determinants of the cardiometabolic phenotype.

Authors:  Lisa de las Fuentes; Giovanni de Simone; Donna K Arnett; Víctor G Dávila-Román
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-06       Impact factor: 2.895

4.  Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.

Authors:  Laura D Baker; Donna J Cross; Satoshi Minoshima; Dana Belongia; G Stennis Watson; Suzanne Craft
Journal:  Arch Neurol       Date:  2010-09-13

5.  Cross-sectional association between sugar-sweetened beverage intake and cardiometabolic biomarkers in US women.

Authors:  Zhi Yu; Sylvia H Ley; Qi Sun; Frank B Hu; Vasanti S Malik
Journal:  Br J Nutr       Date:  2018-03       Impact factor: 3.718

6.  Prevalence and incident prehypertension and hypertension in postmenopausal Hispanic women: results from the Women's Health Initiative.

Authors:  Ruth E Zambrana; Lenny López; Gniesha Y Dinwiddie; Roberta M Ray; Lawrence S Phillips; Maurizio Trevisan; Sylvia Wassertheil-Smoller
Journal:  Am J Hypertens       Date:  2014-01-30       Impact factor: 2.689

7.  Insulin glargine reduces carotid intimal hyperplasia after balloon catheter injury in Zucker fatty rats possibly by reduction in oxidative stress.

Authors:  Subramanyam N Murthy; Sergiy Sukhanov; Jennifer McGee; Joel A Greco; Surabhi Chandra; Patrice Delafontaine; Philip J Kadowitz; Dennis B McNamara; Vivian A Fonseca
Journal:  Mol Cell Biochem       Date:  2009-04-10       Impact factor: 3.396

8.  Impact of performance improvement continuing medical education on cardiometabolic risk factor control: the COSEHC initiative.

Authors:  JaNae Joyner; Michael A Moore; Debra R Simmons; Brian Forrest; Kristina Yu-Isenberg; Ron Piccione; Kirt Caton; Daniel T Lackland; Carlos M Ferrario
Journal:  J Contin Educ Health Prof       Date:  2014       Impact factor: 1.355

9.  Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Authors:  Russell Scott; Richard O'Brien; Greg Fulcher; Chris Pardy; Michael D'Emden; Dana Tse; Marja-Riitta Taskinen; Christian Ehnholm; Anthony Keech
Journal:  Diabetes Care       Date:  2008-11-04       Impact factor: 19.112

10.  Does elevated plasma triglyceride level independently predict impaired fasting glucose?: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Susan X Lin; Ivan Berlin; Richard Younge; Zhezhen Jin; Christopher T Sibley; Pamela Schreiner; Moyses Szklo; Alain G Bertoni
Journal:  Diabetes Care       Date:  2012-10-01       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.